Kirsty Thomson

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Kevin W. Ng, Nikhil Faulkner, Georgina H. Cornish et al. · Science · 2020 · 985 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Emma Morris, Kirsty Thomson, Charles Craddock et al. · Blood · 2004 · 288 citations · Full text

Life Sciences, Immunology, Oncology +11

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Karl S. Peggs, Ann Hunter, Rajesh Chopra et al. · The Lancet · 2005 · 277 citations

Life Sciences, Immunology, Oncology +3

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

Karl S. Peggs, Kirsty Thomson, Edward Samuel et al. · Clinical Infectious Diseases · 2010 · 221 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

Roel J.W. van Kampen, Carmen Canals, Harry C. Schouten et al. · Journal of Clinical Oncology · 2011 · 215 citations · Full text

Medicine, Hematology, Oncology +16